Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.
DNA Polymerase gamma
JCAPN editor transition: a new era begins.
De novo psychogenic nonepileptic seizures after epilepsy surgery.
Cubicin Outcomes Registry and Experience (CORE) methodology.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cubicin Outcomes Registry and Experience (CORE) methodology.
Cubicin Outcomes Registry and Experience (CORE) methodology. Am J Med. 2007 Oct; 120(10 Suppl 1):S4-5.
View in:
PubMed
subject areas
Anti-Bacterial Agents
Daptomycin
Gram-Negative Bacteria
Gram-Negative Bacterial Infections
Humans
Product Surveillance, Postmarketing
Registries
Skin Diseases, Infectious
Time Factors
Treatment Outcome